Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporti... Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. Mehr anzeigen
MIAMI, FL, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
MIAMI, FL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
MIAMI, FL, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
MIAMI, FL, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
MIAMI, FL, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0272 | 4.29835651075 | 0.6328 | 0.88 | 0.6297 | 2673332 | 0.65566563 | CS |
| 4 | -0.0845 | -11.3498992612 | 0.7445 | 0.88 | 0.6 | 1558608 | 0.68395967 | CS |
| 12 | -0.25 | -27.4725274725 | 0.91 | 0.999 | 0.575 | 1121555 | 0.72229456 | CS |
| 26 | -0.21 | -24.1379310345 | 0.87 | 1.13 | 0.575 | 893615 | 0.79211087 | CS |
| 52 | -0.08 | -10.8108108108 | 0.74 | 1.92 | 0.36 | 1549275 | 0.91295105 | CS |
| 156 | -5.25 | -88.8324873096 | 5.91 | 24.55 | 0.36 | 4430853 | 9.94059974 | CS |
| 260 | -2.69 | -80.2985074627 | 3.35 | 24.56 | 0.36 | 3382134 | 9.85441973 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
